Work We Do

Agonist guides collaboration between information-intensive healthcare organizations to radically improve patients’ lives. We concentrate on win-win propositions and strategize only to the extent we can ensure execution. Our team holds deeply relevant experience across many sectors and functions, including:

  • Emerging real world evidence and clinical research business models

  • Development-stage and post-launch pharmaceutical life cycles

  • Three-dimensional views of the health data landscape, from valuation and interoperability to privacy and compliance

  • Deep payer and pharmacy benefit manager-derived perspectives on information value and life sciences interactions

CASE STUDY

Leading Edge Research Technology Needs Data Roadmap

A next-generation clinical trials technology firm was highly focused on core development but needed to scope and explore data enrichment from external real world sources. Agonist Health was engaged to develop a comprehensive partnership roadmap.

Agonist Engagement:

  • Assessment of ongoing data-related initiatives

  • Analysis of partnership landscape within distinct RWE subsectors

  • Systematic approach to partner comparisons, including external and Client-internal factors

  • Establishment of actionable data partnership priorities

Agonist Deliverables:

  • 3 year partnership trajectory for Client to deploy and refine

  • Quantitative scoring of dozens of potential partners

  • Scenario assessments and competitive comparisons

  • Presentation of highest value sectors and partners

  • 4-6 critical partnership “pathways,” including alternatives, timelines

CASE STUDY

Aggregator Pursues New Enabling Offerings

A major multinational health data aggregator wished to leverage its deep scale and experience to develop a critical enabling offering in the real world data space. They sought a robust understanding of competitive efforts and a comprehensive plan for enlisting data partners. Agonist was engaged to identify an exhaustive data supplier roster and chart the competitive landscape.

Agonist Engagement:

  • Systematic evaluation of data partner alternatives by broad category

  • Development of comprehensive value propositions from perspective of data partners and life sciences end-customers

  • Profiling of existing and emerging competitors to relevant client offerings

Agonist Deliverables:

  • Deep analysis of over 80 current and potential data partners

  • Design of quantitative partner assessment tool, scoring multiple data criteria

  • Field-based, direct competitive assessments

  • Assembly of critical end-customer and sales channel feedback

  • Blueprint to drive data partner engagement and inclusion

CASE STUDY

Analytics Platform Searches for New Growth

An emerging real world evidence analytics company was seeking new opportunities for its core platform offering, within healthcare and beyond. Agonist was engaged to identify, evaluate and prioritize new markets.

Agonist Engagement:

  • Market sizing and key strategic attributes

  • Systematic prioritization of revenue generating adjacencies

  • Gap analysis/assessment of current capability offerings and limitations

  • Development of preliminary go-to-market strategies

Agonist Deliverables:

  • Comprehensive assessment of five critical go-to-market opportunities

  • Quantitative analysis and ranking of top three alternatives

  • Extensive cross-functional feasibility assessment within client leadership

  • Immediate and 3-5 month action plans for execution against leading market opportunities

Capabilities

  • Information Monetization and Mobility

  • Data Driven Acceleration of Clinical Trials

  • Value Dynamics in Pharma and Life Sciences

  • Digital Health’s Data Foundation